Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis
Biopharmaceutics and Drug Disposition - United Kingdom
doi 10.1002/bdd.2130
Full Text
Open PDFAbstract
Available in full text
Date
April 21, 2018
Authors
Publisher
Wiley